Tarsus Pharmaceuticals, Inc. (TARS) earnings
TARS earnings moved a median of +0.56% by the close. Quarterly and annual TARS reports and results, each read against the price at its own news timestamp. Back to the TARS overview →
28 measured TARS earnings events.
Where these TARS earnings landedvs 28 measured TARS earnings reactions
| Middle 50% of TARS earnings reactions | -2.08% to +3.01% |
|---|---|
| Median reaction (to close) | +0.56% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 TARS earnings events with a measured close landed between -2.08% and +3.01%; 54% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Tarsus Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +4.09% | +13.36% | |
| Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth | Press release | +4.09% | +13.36% | |
| Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 | Press release | +4.09% | +13.36% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -2.15% | +2.01% | |
| Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements | Press release | -2.15% | +2.01% | |
| Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026 | Press release | +2.01% | +5.00% | |
| Form 10-K Tarsus Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +3.90% | +0.62% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.93% | -0.44% | |
| Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements | Press release | +0.93% | -0.44% | |
| Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 | Press release | +0.06% | -0.49% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +2.40% | +6.63% | |
| Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements | Press release | +2.40% | +6.63% | |
| Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 | Press release | -0.35% | -2.41% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -4.97% | -4.55% | |
| Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements | Press release | -4.97% | -4.55% | |
| Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 | Press release | -0.71% | +0.95% | |
| Form 10-K Tarsus Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.85% | +0.50% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -1.72% | -8.53% | |
| Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024 | Press release | +1.62% | +2.25% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -4.18% | -0.56% | |
| Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 | Press release | +1.55% | -1.96% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -4.79% | -19.91% | |
| Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements | Press release | -4.79% | -19.91% | |
| Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024 | Press release | +0.69% | +5.87% | |
| Form 10-K Tarsus Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -1.94% | -6.26% | |
| Form 10-Q Tarsus Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +5.54% | +2.34% | |
| Tarsus Reports Third Quarter 2023 Financial Results and Recent Business Achievements | Press release | +5.54% | +2.34% | |
| Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023 | Press release | +1.29% | -0.74% |
Keep exploring
More TARS: analyst actions → · SEC filings → · TARS overview →